Table 5 Lipid parametersa in the all-exposed population (n = 4,009)
| Parameter (mg/dl) | Baseline | Week 6 | Week 52b | Week 104 |
|---|---|---|---|---|
| Mean total cholesterol |
196.2 (n = 3,714) |
227.6 (n = 3,279) |
222.9 (n = 1,312) |
224.1 (n = 828) |
| Mean LDL cholesterol |
114.2 (n = 3,633) |
135.5 (n = 3,149) |
133.5 (n = 1,274) |
134.3 (n = 805) |
| Mean HDL cholesterol |
56.9 (n = 3,656) |
60.8 (n = 3,249) |
60.0 (n = 1,301) |
60.0 (n = 826) |
| Mean triglycerides |
127.6 (n = 3,715) |
160.4 (n = 3,280) |
148.8 (n = 1,312) |
148.8 (n = 828) |
|
Patients starting lipid-lowering medication at any time up to week 104 during the trial (n = 456) | ||||
| Mean total cholesterol |
223.3 (n = 415) |
267.4 (n = 375) |
247.7 (n = 154) |
236.1 (n = 109) |
| Mean LDL cholesterol |
135.1 (n = 402) |
167.6 (n = 338) |
152.9 (n = 142) |
138.9 (n = 97) |